BBVA USA Bancshares’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
MPI
BBVA USA Bancshares's CLB Position: Q1 2020 in Review
BBVA USA Bancshares sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 9,592 shares — an estimated $362K sold.
BBVA USA Bancshares first reported a position in CLB in Q2 2015 and held it in 19 quarters. The position peaked at $1.34M in Q2 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.
- BBVA USA Bancshares reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
- BBVA USA Bancshares sold 9,592 Core Laboratories shares in Q1 2020, an estimated $362K.
- BBVA USA Bancshares first reported a position in Core Laboratories in Q2 2015 and held it in 19 quarters.
- BBVA USA Bancshares's Core Laboratories position peaked at $1.34M in Q2 2018.
- 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.
Based on BBVA USA Bancshares's 13F filing for Q1 2020, filed 27 Apr 2020.